What Researchers Did
The researchers searched medical databases for randomised controlled trials that compared hyperbaric oxygen therapy (HBOT) with no HBOT, or with a sham treatment, in people with an acute ischaemic stroke, and combined the results.
What They Found
This Cochrane systematic review of three randomised controlled trials (106 participants) found no evidence that HBOT improved clinical outcomes when given during the acute phase of ischaemic stroke. Death rates at six months did not differ significantly between the HBOT and control groups (relative risk 0.61, 95% confidence interval 0.17 to 2.2, p value 0.45). Two of 15 disability and function scales showed an improvement with HBOT at one year: the Trouillas Disability Scale (2.2 point reduction, p value 0.04) and the Orgogozo Scale (27.9 point difference, p value 0.02). The authors state that these improvements were not reflected in other trials or other functional scales.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
Only three small trials with 106 participants in total could be pooled, and the data could be combined for only a limited number of outcomes, so the evidence was too limited to give clear guidelines for practice.